Upgrade to SI Premium - Free Trial

Anika Therapeutics (ANIK)

14.79 +0.38 (2.64%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/26)

Latest Headlines

Form DEFA14A Anika Therapeutics, Inc. June 1, 2026 11:13 AM - SEC Filing Form 4 Anika Therapeutics, Inc. For: May 01 Filed by: HENNEMAN JOHN B III May 4, 2026 8:34 AM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Apr 30 Filed by: Griffin Stephen D. April 30, 2026 5:23 PM - SEC Filing TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter April 30, 2026 4:43 PM - Globe NewsWire Form 10-Q Anika Therapeutics, Inc. For: Mar 31 April 30, 2026 6:10 AM - SEC Filing Form SCHEDULE 13G Anika Therapeutics, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 4:37 PM - SEC Filing Form 8-K Anika Therapeutics, Inc. For: Apr 24 April 29, 2026 7:20 AM - SEC Filing Anika Therapeutics (ANIK) Tops Q1 EPS by 45c ; Offers Guidance April 29, 2026 7:12 AM - StreetInsider Anika Reports First Quarter 2026 Financial Results April 29, 2026 7:05 AM - Globe NewsWire Form ARS Anika Therapeutics, Inc. For: Dec 31 April 28, 2026 4:53 PM - SEC Filing Form DEFA14A Anika Therapeutics, Inc. April 28, 2026 4:51 PM - SEC Filing Form DEF 14A Anika Therapeutics, Inc. For: Jun 18 April 28, 2026 4:48 PM - SEC Filing Xilio Therapeutics adds Cheryl Blanchard to board of directors April 16, 2026 11:42 AM - StreetInsider Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors April 16, 2026 11:42 AM - Globe NewsWire Xilio Therapeutics adds Cheryl Blanchard to board, Rossi steps down April 16, 2026 7:32 AM - StreetInsider Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors April 16, 2026 7:31 AM - StreetInsider Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 April 15, 2026 4:01 PM - StreetInsider Telix Strengthens Board with Additional Director Appointments April 8, 2026 6:44 PM - Globe NewsWire Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 3, 2026 5:00 PM - StreetInsider Form SCHEDULE 13G/A Anika Therapeutics, Inc. Filed by: VANGUARD GROUP INC March 26, 2026 3:49 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Mar 19 Filed by: McLeod Ian March 23, 2026 5:23 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Mar 14 Filed by: Colleran David March 17, 2026 7:47 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Mar 14 Filed by: Griffin Stephen D. March 17, 2026 7:44 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Mar 14 Filed by: Blanchard Cheryl R March 17, 2026 7:42 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Mar 14 Filed by: McLeod Ian March 17, 2026 7:40 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Mar 09 Filed by: Colleran David March 11, 2026 4:25 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Mar 09 Filed by: Blanchard Cheryl R March 11, 2026 4:25 PM - SEC Filing Form 4 Anika Therapeutics, Inc. For: Mar 09 Filed by: McLeod Ian March 11, 2026 4:25 PM - SEC Filing Full Article List